Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 3Thoracic 1

Conditions

Lymphoma, Follicular 1Bronchial Hyperreactivity 1Asthma 1

Interventions

Gemcitabine 4tazemetostat 2pembrolizumab 2Rituximab 2Itraconazole 2Cyclophosphamide 2Cisplatin 2vandetanib 1utomilumab 1temsirolimus 1sargramostim 1ruxolitinib 1motexafin gadolinium 1motesanib diphosphate 1fludarabine 1enzalutamide 1entinostat 1carboxyamido-triazole 1avelumab 1Watchful Waiting 1Vorinostat 1Topotecan 1Thalidomide 1Ritonavir 1Rifampin 1Radiotherapy 1Polymerase Chain Reaction 1Pemetrexed 1Paclitaxel 1PF06821497 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphoma, Follicular × Fluticasone × Thoracic × Clear all
NCT00455923 2018-02-05

SERETIDE Vs FLIXOTIDE In Mild Persistent Asthma (GINAII)

GlaxoSmithKline

Phase 4 Completed
100 enrolled 8 charts
LymphoidThoracic

Asthma, Lymphoma, Follicular, Bronchial Hyperreactivity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡